You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Business

  • In Russia, oil boss's arrest like days past
    MOSCOW – The arrest of a Russian telecommunications and oil tycoon has sent shock waves through the country’s business community, with some fearing a return to the dark days of a decade ago when the Kremlin asserted its power by
  • Consumer prices fall, easing inflation fears
    WASHINGTON – U.S. consumer prices edged down in August, the first monthly drop since the spring of 2013, as gasoline, airline tickets and clothing prices all fell.
  • Dow closes at record after Fed keeps rates intact
    NEW YORK – The stock market rose Wednesday after the Federal Reserve told investors to expect low interest rates for a while yet, pushing the Dow Jones industrial average to a record high.
Advertisement

Equity owners may act to sell stake in Biomet

Biomet Inc.’s private equity owners might be looking to sell their stake in the Warsaw-based orthopedic devices maker, a financial newspaper reported this week.

The Financial Times of London reported Monday that the owners are considering taking the manufacturer public or selling it to another investment group. The publication said it relied on three unnamed sources for the information.

Barbara Goslee, Biomet spokeswoman, said Wednesday that the company doesn’t comment on speculation.

In 2007, a private-equity consortium paid $11.4 billion for Biomet, a transaction the new owners characterize as a merger. The private-equity group includes affiliates of Blackstone Group, Goldman Sachs & Co., Kohlberg Kravis Roberts & Co. and Texas Pacific Group, along with Dane Miller, a Biomet founder and former chief executive.

Miller couldn’t be reached Wednesday for comment.

Brad Bishop, executive director of the nonprofit industry group OrthoWorx, said anyone involved in strategic talks that could lead to a sale would be prohibited from talking publicly about it until a formal announcement was issued.

Biomet employs about 8,000 worldwide, including about 1,500 in Warsaw.

On July 17, 2012, the company reported fiscal 2012 financial results, including a net loss of almost $458 million for the 12 months ended May 31, 2012.

Biomet has not yet released a financial report for fiscal 2013, which ended May 31.

sslater@jg.net

Advertisement